High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer

By Choi In Keun   Kim Yeul Hong   Kim Jun Suk   Seo Jae Hong  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 861-864

Informa Healthcare

Access to resources Recommend Favorite

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

By Wang Fenghua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 331-335

Humana Press, Inc

Access to resources Recommend Favorite

Overexpression of Metastasis-Associated Protein 1 is Significantly Correlated with Tumor Angiogenesis and Poor Survival in Patients with Early-Stage Non-Small Cell Lung Cancer

By Li Shu-hai  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 2048-2056

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Factors for the Survival of Surgically Treated Patients for Non-Small Cell Lung Cancer

By Fernandes Oswaldo J.C.B.   Almgren Stig-olof   Thaning Lars   Filbey Derek   Helsing Martin   Karlsson Mats   Magnusson Anders   Souza Domingos  

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 338-341

Informa Healthcare

Access to resources Recommend Favorite

Human leukocyte antigenhaploidentical donorderived cytokineinduced killer cells are safe and prolong the survival of patients with advanced nonsmall cell lung cancer

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2727-2733

Spandidos Publications

Access to resources Recommend Favorite